Healthcare insurance company UnitedHealth (UNH) has appointed Tim Noel as its new CEO following the killing of former CEO Brian Thompson in December. Noel is a company veteran who joined in 2007 and has a strong track record in the industry. He was also the head of Medicare and retirement at UnitedHealth.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The appointment comes at a challenging time for the company, which is still being impacted by Thompson’s murder. The incident caused outrage and calls for healthcare reform. In response, UnitedHealth Group has increased security measures for its executives and removed personal information from its website. The company is also dealing with rising medical costs associated with Medicare Advantage plans, which have been a key source of growth and profits for the industry.
Despite these challenges, UnitedHealth Group remains a big player in the U.S. healthcare market. In fact, the company reported $400.3 billion in revenue for 2024 and guided for $450-455 billion in 2025. However, CEO Andrew Witty has acknowledged that the U.S. healthcare system “needs to function better” and be “less confusing, less complex, and less costly.”
What Is the Future of UNH Stock?
Overall, analysts have a Strong Buy consensus rating on UNH stock based on 18 Buys assigned in the past three months. After a 4% rally in its share price over the past year, the average UNH price target of $650.19 per share implies 23% upside potential.
